Issued Patents All Time
Showing 26–50 of 140 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9663460 | Sulfur derivatives as chemokine receptor modulators | Haiqing Yuan, Richard L. Beard, Michael E. Garst, Xiaoxia Liu, Veena Viswanath | 2017-05-30 |
| 9637467 | Treatment of inflammatory bowel disease | Yariv Donde, Jeremiah H. Nguyen, Karen M. Kedzie, Daniel W. Gil, Wha-Bin Im | 2017-05-02 |
| 9623006 | Methods of treating α adrenergic mediated conditions | Daniel W. Gil, Wenkui K. Fang, Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh +3 more | 2017-04-18 |
| 9603834 | 1,2- bis-sulfonamide derivatives as chemokine receptor modulators | Haiqing Yuan, Richard L. Beard, Michael E. Garst, Xiaoxia Liu, Veena Viswanath | 2017-03-28 |
| 9579307 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | Richard L. Beard, Tien T. Duong, Veena Viswanath, Michael E. Garst | 2017-02-28 |
| 9550746 | Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators | Haiqing Yuan, Richard L. Beard, Xiaoxia Liu, Veena Viswanath, Michael E. Garst | 2017-01-24 |
| 9545394 | Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists | Daniel W. Gil, Veena Viswanath, Lauren M. Luhrs | 2017-01-17 |
| 9522150 | Alpha adrenergic receptor modulators | Ken Chow, Liming Wang, Wenkui K. Fang, Evelyn G. Corpuz, Santosh C. Sinha +2 more | 2016-12-20 |
| 9492543 | Compositions for treating cognitive disorders | Ursula V. Staubli | 2016-11-15 |
| 9428549 | Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators | Richard L. Beard, Tien T. Duong, Veena Viswanath, Michael E. Garst | 2016-08-30 |
| 9416120 | Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators | Haiqing Yuan, Richard L. Beard, Michael E. Garst, Xiaoxia Liu, Veena Viswanath | 2016-08-16 |
| 9399628 | 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity | Bertrand Leblond, Eric Beusoleil, Thierry Taverne | 2016-07-26 |
| 9371278 | Sulfur derivatives as chemokine receptor modulators | Haiqing Yuan, Richard L. Beard, Xiaoxia Liu, Veena Viswanath, Michael E. Garst | 2016-06-21 |
| 9351948 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | Richard L. Beard, Tien T. Duong, Veena Viswanath, Michael E. Garst | 2016-05-31 |
| 9328067 | Sulfur derivatives as chemokine receptor modulators | Haiqing Yuan, Richard L. Beard, Xiaoxia Liu, Veena Viswanath, Michael E. Garst | 2016-05-03 |
| 9314466 | Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds | Fabien J. Schwieghoffer, Lauren M. Luhrs | 2016-04-19 |
| 9308201 | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | Mohammed I. Dibas, Edward C. Hsia, Daniel W. Gil | 2016-04-12 |
| 9303021 | Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds | Fabien J. Schweighoffer, Lauren M. Luhrs | 2016-04-05 |
| 9289420 | Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists | Daniel W. Gil, Veena Viswanath, Lauren M. Luhrs | 2016-03-22 |
| 9283217 | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | Mohammed I. Dibas, Edward C. Hsia, Daniel W. Gil | 2016-03-15 |
| 9278943 | Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds | Bertrand Leblond, Eric Beausoleil, Thierry Taverne, Fabien Schweighoffer | 2016-03-08 |
| 9200016 | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) | Bertrand Leblond, Thierry Taverne, Cedric Chauvignac, Eric Beausoleil, Anne-Sophie Casagrande +3 more | 2015-12-01 |
| 9156810 | Treatment of inflammatory bowel disease | Yariv Donde, Jeremiah H. Nguyen, Karen M. Kedzie, Daniel W. Gil, Wha-Bin Im | 2015-10-13 |
| 9095576 | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases | Mohammed I. Dibas, Daniel W. Gil | 2015-08-04 |
| 9090624 | Aromatic bycyclic derivatives as CXCR4 receptor modulators | Vidyasagar Vuligonda, Richard L. Beard, Thong Vu, Gerard A. Rodrigues, Veena Viswanath +1 more | 2015-07-28 |